Literature DB >> 30074171

Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis.

Stergios A Polyzos1, Evangelos Terpos2.   

Abstract

Entities:  

Keywords:  Adverse event; Denosumab; Leukocyte count; Leukopenia; Receptor activator of nuclear factor kappa B ligand; Side effect

Mesh：

Substances：

Year:  2018        PMID： 30074171     DOI： 10.1007/s12020-018-1699-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  3 in total

1.  Late-onset neutropenia following rituximab treatment for rheumatologic conditions.

Authors:  Gabriel S Breuer; Michael Ehrenfeld; Itzhak Rosner; Alexandra Balbir-Gurman; Devy Zisman; Shirley Oren; Daphna Paran
Journal:  Clin Rheumatol       Date:  2014-03-06       Impact factor: 2.980

Review 2.  THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Polyzois Makras
Journal:  Eur J Endocrinol       Date:  2018-04-24       Impact factor: 6.664

3.  Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab.

Authors:  Athanasios D Anastasilakis; Konstantinos A Toulis; Stergios A Polyzos; Chrysostomos D Anastasilakis; Polyzois Makras
Journal:  Ther Clin Risk Manag       Date:  2012-06-19       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.